Zimmer Biomet Appoints Senior VP of Investor Relations

Coleman Lannum

Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now

This audio file is brought to you by

0:00

0:00

Loading audio file, please wait.

Speed
1.00

• 0.25
• 0.50
• 0.75
• 1.00
• 1.25
• 1.50
• 1.75
• 2.00

Warsaw-based Zimmer Biomet Holdings Inc. has appointed Coleman Lannum senior vice president of investor relations. He has more than 15 years of Investor Relations experience in the healthcare industry. Most recently, Lannum served in a similar role for Mallinckrodt Pharmaceuticals.

Prior to joining Mallinckrodt in 2015, he led IR at Covidien and Tyco Healthcare for nine years. As vice president and investor relations officer, he designed Covidien’s IR program, oversaw the largest-ever healthcare Initial Public Offering and led the IR effort through the company’s merger with Medtronic in 2015.

Lannum’s leadership at Covidien and Mallinckrodt has been recognized with numerous best-in-class honors, including an unprecedented five consecutive awards by IR Magazine for both Best US Investor Relations Officer – Large Cap and Grand Prix – Best Overall Investor Relations from 2011 through 2015.